Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Contrave
Contrave
Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale
Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale
Xconomy
Orexigen
bankruptcy
Contrave
Flag link:
Troubled Orexigen looks for a buyer, but will anyone want Contrave?
Troubled Orexigen looks for a buyer, but will anyone want Contrave?
Fierce Pharma
Orexigen Therapeutics
Contrave
M&A
Flag link:
Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns
Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns
Endpoints
Orexigen
Contrave
M&A
Flag link:
The FDA cites risk info in letter over Contrave DTC ad
The FDA cites risk info in letter over Contrave DTC ad
Medical Marketing and Media
FDA
Contrave
drug ads
Orexigen Therapeutics
Flag link:
Orexigen - Contrave Sales Present Troubling Data
Orexigen - Contrave Sales Present Troubling Data
Seeking Alpha
Orexigen
Contrave
obesity
Flag link:
Orexigen struggles to stay afloat as obesity market stagnates
Orexigen struggles to stay afloat as obesity market stagnates
BioPharma Dive
Orexigen
obesity
Contrave
Vivus
Qsymia
Takeda
Flag link:
Orexigen Pulls The Plug On Post-Marketing Cardiovascular Trial
Orexigen Pulls The Plug On Post-Marketing Cardiovascular Trial
Seeking Alpha
Orexigen
Contrave
Flag link:
Orexigen: Contrave Sales Flatten Out At End Of Q1
Orexigen: Contrave Sales Flatten Out At End Of Q1
Seeking Alpha
Orexigen
Contrave
obesity
Novo Nordisk
Vivus
Arena Pharmaceuticals
Flag link:
Orexigen buys U.S. obesity pill rights from Takeda, partners Valeant
Orexigen buys U.S. obesity pill rights from Takeda, partners Valeant
Yahoo/Reuters
Orexigen
obesity
Contrave
Takeda
Valeant Pharmaceuticals
M&A
Flag link:
Orexigen takes another body blow from ill-fated Contrave trial
Orexigen takes another body blow from ill-fated Contrave trial
Fierce Pharma
Orexigen
Contrave
obesity
Takeda
clinical trials
Flag link:
Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says
Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says
Fierce Pharma Marketing
obesity
Vivus
Orexigen
Contrave
Qsymia
Takeda
Flag link:
Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says
Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says
Fierce Pharma Marketing
Takeda
Contrave
drug reps
Orexigen
Flag link:
Contrave script growth snags, despite Takeda's 900-strong salesforce
Contrave script growth snags, despite Takeda's 900-strong salesforce
Fierce Pharma Marketing
Contrave
Takeda
Orexigen
obesity
Flag link:
Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet?
Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet?
Motley Fool
Orexigen
Europe
drug launches
obesity
Mysimba
Contrave
Flag link:
Here's What Caused Orexigen Therapeutics to Slim Down in August
Here's What Caused Orexigen Therapeutics to Slim Down in August
Motley Fool
Orexigen Therapeutics
Takeda
Contrave
Flag link:
Orexigen - Contrave Takes Sales Lead In The U.S. - More Sales Still Needed
Orexigen - Contrave Takes Sales Lead In The U.S. - More Sales Still Needed
Seeking Alpha
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Flag link:
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Flag link:
Orexigen, Takeda take Actavis to court over obesity med Contrave generic
Orexigen, Takeda take Actavis to court over obesity med Contrave generic
BioPharma Dive
Orexigen
Takeda
Actavis
obesity
generics
Contrave
Flag link:
Orexigen and Takeda File Lawsuit Against Actavis for Infringement of Contrave® Patents
Orexigen and Takeda File Lawsuit Against Actavis for Infringement of Contrave® Patents
Yahoo
Orexigen
Takeda
Actavis
patents
Contrave
Flag link:
Vivus: Qsymia Sales Flatten Again - Third Place Out Of 3 Drugs Nothing To Celebrate
Vivus: Qsymia Sales Flatten Again - Third Place Out Of 3 Drugs Nothing To Celebrate
Seeking Alpha
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Belviq
Contrave
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »